- Pharma
- July 10, 2020
- 158 views
Premas Biotech SARS-Cov-2 Vaccine Candidate moves for Animal Trials
Gurgaon: Gurgaon-based Premas Biotech, which developed the world’s first triple antigen virus-like particle (VLP) vaccine candidate for SARS CoV-2 virus, announces that it has progressed into animal trials. At the…